TTO Flanders is een gezamenlijk initiatief van de Universiteit Gent, Universiteit Antwerpen, KU Leuven, Vrije Universiteit Brussel en Universiteit Hasselt. De technology transfer offices (TTOs) van deze universiteiten staan in voor de kennis- en technologietransfer van de universiteiten en geassocieerde hogescholen naar private en publieke partners.
Interesse in samenwerking? Ontdek ons op knowledge for growth
Tijdens de Research-to-Business-sessie, zullen onderzoekers en business developers van alle Vlaamse universiteiten een aantal projecten pitchen. De geselecteerde valorisatieprojecten bestrijken een ruim toepassingsgebied en de onderzoeksteams zijn actief op zoek naar partners voor verdere ontwikkeling of potentiële klanten.
Tijdens de pauzes van de conferentie vind je ons in de posterhal waar 15 academische showcases gedemonstreerd worden.
TTO Flanders R2B pitches:
- µFlow Cell - Valorization of Microfluidics (VUB)
- The sPDGFR-beta containing PRTA-score is a novel serological diagnostic algorithm for significant liver fibrosis (VUB)
- Probiotic formulations targeting the respiratory tract (UAntwerp)
- MinTR immunoinformatics platform (UAntwerp)
- APN targeting: Entry portal through the intestinal barrier (UGent)
- Recombinant extracellular vesicles (R-EV) as reference standard for Biofluid processing and instrument calibration (UGent)
- Shifting insights into the pathogenesis & treatment of PolyCystic Ovary Syndrome (PCOS) (KU Leuven)
- A profibrinolytic diabody targeting PAI-1 and TAFI for treatment of acute thrombotic disorders (KU Leuven)
- Regulation of phosphosdiesterase 4D (PDE4D) as a new approach to stimulate repair in multiple sclerosis (UHasselt)
- Early inflammation associated biomarkers as a potential diagnostic tool in chronic diseases (UHasselt)
Meer details over de pitches vindt u op https://knowledgeforgrowth.be/exhibit/r2b-by-tto-flanders/
TTO Flanders Academic Showcases:
- Human robotics – bionic prostheses (VUB)
- in vitro hepatic cell model for both drug-induced liver disease (DILI) prediction and anti-NASH/NAFLD drug discovery (VUB)
- Bioinformatics: MutaFrame, unraveling the Human Proteome (VUB)
- NarcoReader: On-site accurate detection of illicit drugs (UAntwerp)
- Anicells – State-of-the-art manufacturing site for cell-based therapeutic products (UAntwerp)
- PET awake: imaging of interacting animals (UAntwerp)
- LumiPoreTM platform - proprietary benchtop device for state-of-the-art cell transfections (UGent)
- Nanodelivery expertise. Delivery is key to ensure that the full potential of an API is properly unfolded. (UGent)
- OhmX.Bio unravelling genome-wide maps of translated mRNA (UGent)
- Liquid Biopsies, Single-Cell Genomics, Whole Genome Diagnostics (KU Leuven)
- A zebrafish platform for toxicity assessment and neuroactive drug discovery (KU Leuven)
- An on-chip single B cell mining platform for rapid development of fully human therapeutic antibodies and for immunoprofiling human antibody responses (KU Leuven)
- Planarian stem cells as a tool for carcinogenic screening (UHasselt)
- Relab Measuring of functional movements with XSENS system on persons with degenerative joint problems (UHasselt)
- Multiple Sclerosis in vitro-to-patient toolbox (UHasselt)
Meer details over de showcases vindt u op https://knowledgeforgrowth.be/exhibit/tto-flanders-academic-showcase/